Table 1 Baseline Demographics and Patient Characteristics Assessed for Predictive Value of Early Visual Acuity Outcomes
Baseline predictors of early achievement of BCVA 20/40 or better (Snellen equivalent) | |
BCVA (≤ 50, > 50) Subretinal fluid Total macular volume (≤ 9.99 mm3, > 9.99 mm3) | |
Baseline predictors of early first BCVA gain of 15 or more ETDRS letters | |
Sex | |
Variables that did not have a predictive value on visual outcomes | |
Age (≤ 60 years, > 60 years) Race BMI (< 30 kg/m2, ≥ 30 kg/m2) Disease type (BRVO/HRVO vs CRVO) Months since RVO diagnosis Smoking status Hypertension Diabetes Prior RVO therapies | Central subfield thickness (≤ 400 μm, > 400 μm) Edema Cystoid space Retinal hemorrhage Diffuse edema BCVA (≤ 35, 35–50, > 50 ETDRS letters) Treatment group DBP (< 80 mmHg, ≥ 80 mmHg) SBP (< 140 mmHg, ≥ 140 mmHg) |